FINWIRES · TerminalLIVE
FINWIRES

Integral Diagnostics to Conduct Independent Audit After Reports of Alleged Inappropriate Billing at Western Australia Hospital, Shares Reach Two-Year Low

By

Integral Diagnostics (ASX:IDX) is set to conduct an independent audit to confirm that there are no billing anomalies related to its unit, Apex Radiology, "out of an abundance of caution," noting recent media reports alleging inappropriate billing practices by the said unit at the Kalgoorlie Hospital in Western Australia, according to a Tuesday Australian bourse filing.

The firm said that it was not aware of any such inappropriate billing practices at the hospital.

Apex Radiology has an agreement with the state government entity, WA Country Health Service (WACHS), to provide radiologist reporting services across several hospitals, including the Kalgoorlie Hospital.

WACHS staff conduct diagnostic imaging in the Kalgoorlie Hospital, with a magnetic resonance imaging technician provided by Apex.

Its shares declined 4% in recent trading on Tuesday, reaching their lowest point in over two years.

Related Articles

Asia

Cosmo Chemical Shares Rise 6% on KRW15.5 Billion EcoPro Supply Deal

Cosmo Chemical (KRX:005420) secured a supply contract for cobalt sulfate, a secondary battery cathode material, from EcoPro (KOSDAQ:086520) subsidiary EcoPro EM, according to a Tuesday Korea Exchange filing.The contract, worth 15.47 billion won, is valid till Dec. 31, 2031.Shares of Cosmo Chemical rose nearly 6% in recent trade.

$KOSDAQ:086520$KRX:005420
Asia

Grasim Industries Earmarks INR31 Billion Capex for Lyocell Capacity Expansion

Grasim Industries (NSE:GRASIM, BOM:500300) has received board approval for Phase II expansion of its Lyocell capacity in Harihar, Karnataka, involving capital expenditure of 30.9 billion Indian rupees, according to a Monday filing with the Indian bourses.The expansion will be executed in two phases, adding a total capacity of 110,000 tonnes per annum (TPA) through two 55,000 TPA lines. The first phase is expected to be completed by mid-2028, followed by the second phase by mid-2030.The Phase II expansion will complement Phase I of its Lyocell plant in Harihar, which is already under construction and is expected to be commissioned by mid-2027, the filing stated.

$BOM:500300$NSE:GRASIM
Asia

SEC Wins KRW4.2 Billion Equipment Supply Order from Hanwha Aerospace

South Korean tech and inspection company SEC (KOSDAQ:081180) won an order from Hanwha Aerospace (KRX:012450) to supply the latter with non-destructive testing equipment, according to a Tuesday filing with the Korea Exchange.The contract, worth 4.2 billion won, is valid till Dec. 31, 2027.Shares of Hanwha Aerospace rose nearly 1% in recent trade.

$KOSDAQ:081180$KRX:012450